Table 3.
Percentages of patients reporting reduction in medication after obstructive sleep apnea treatment
| Comorbidities | CPAP users | Non-CPAP treatment (n = 40) (%) |
P* value | |
|---|---|---|---|---|
| Compliant (n = 40) (%) | Non-compliant (n = 48) (%) | |||
| Hypertension | 28 | 5 | 0 | 0.05 |
| Diabetes | 12 | 0 | 0 | 1 |
| CVD | 12 | 0 | 0 | 1 |
| Asthma | 0 | 0 | 0 | N/A |
| GERD | 36 | 0 | 0 | N/A |
| Depression | 14 | 0 | 0 | 0.43 |
| Overall medication reduction | 38 | 3 | 0 | < 0.001 |
*Represents P value of the test difference between the CPAP compliant and non-compliant groups. CPAP = continuous positive airway pressure; CVD = cardiovascular diseases, including angina, arrhythmia, and /or congestive cardiac failure; GERD = gastroesophageal reflux disease; N/A = not applicable